Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
Clinical trial NCT03850418 · RECRUITING
Trial details
- NCT number
- NCT03850418
- Sponsor
- Henry Ford Health System
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2028-02-20
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.